Winslow Evans & Crocker’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$7K Hold
175
﹤0.01% 1023
2020
Q3
$6K Hold
175
﹤0.01% 847
2020
Q2
$5K Sell
175
-1
-0.6% -$26 ﹤0.01% 888
2020
Q1
$6K Hold
176
﹤0.01% 820
2019
Q4
$8K Hold
176
﹤0.01% 876
2019
Q3
$6K Hold
176
﹤0.01% 919
2019
Q2
$6K Hold
176
﹤0.01% 938
2019
Q1
$6K Buy
+176
New +$4.7K ﹤0.01% 937

Other funds holding LMAT

Winslow Evans & Crocker's LMAT Position: Q4 2020 in Review

Winslow Evans & Crocker held its LeMaitre Vascular (LMAT) position steady in Q4 2020 at 175 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Winslow Evans & Crocker first reported a position in LMAT in Q1 2019 and has held it in 8 quarters since. The position peaked at $8K in Q4 2019. 179 funds tracked by Wall St. Rank hold LMAT as of Q4 2020.

  • Winslow Evans & Crocker held 175 shares of LeMaitre Vascular worth $7K as of Q4 2020.
  • Winslow Evans & Crocker left its LeMaitre Vascular share count unchanged in Q4 2020.
  • LeMaitre Vascular made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1023 holding.
  • Winslow Evans & Crocker first reported a position in LeMaitre Vascular in Q1 2019 and has held it in 8 quarters since.
  • Winslow Evans & Crocker's LeMaitre Vascular position peaked at $8K in Q4 2019.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.